Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Myasthenia Gravis × Prednisone × Clear all

Phase

Status

Unknown 2 Not yet recruiting 2 Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 27 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia 6 Burkitt Lymphoma 6 Neoplasms 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Lymphoma, B-Cell 5 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Lymphoma, T-Cell 3 Pain 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphatic Diseases 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Hematologic Diseases 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Prostate Cancer Metastatic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms, Plasma Cell 1

Interventions

thymoglobulin 1 satralizumab 1 rhoA GTP-Binding Protein 1 eculizumab 1 Sugars 1 Steroids 1 Prednisone 1 Methylprednisolone 1 Mesna 1 Immunoglobulins 1 Hizentra 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Cyclophosphamide 1 CK-2017357 1 Bortezomib 1 Amifampridine 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated

11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡